TMO Trading Analysis - 10/23/2026 02:04 PM — TRU-SENTIMENT

News Headlines & Context

Recent general-knowledge headlines and contextual items relevant to Thermo Fisher Scientific (TMO):

• Thermo Fisher reported steady demand in lab equipment and bioprocessing segments through mid-2026, with management citing resilient pharma R&D spending.
• The company went ex-dividend on 2026-09-15 with a $1.88 annual rate, a minor yield of 0.27% based on current price levels.
• Healthcare and life-sciences names saw rotational buying as investors favored lower-beta large caps amid macro uncertainty; TMO beta is 0.71.
• No major negative regulatory or litigation catalyst was widely reported near the observed October 2026 window; stock traded to a 52-week high of $705.79 on 2026-10-21.
• Context: The supportive sector tone aligns with the embedded bullish options flow and strong daily uptrend into late October, though headline risk around guidance remains a standard earnings-related consideration.

Fundamental Analysis

Based strictly on the provided FUNDAMENTALS data:

• Trailing P/E is 36.90 and trailing EPS is $18.61; market cap is $250.94B with 369.75M shares outstanding.
• Dividend yield is 0.27% with rate $1.88 and ex-dividend date 2026-09-15.
• Beta is 0.71 (below 1.0, lower market sensitivity); 52-week range is $435.27 to $705.79 (current price near the high).
• Institutional ownership is 66.21%; average volume is 2.37M shares.
• Historical volatility is 26.75%; fiscal year end was 2025-12-01.
• PEG ratio, forward P/E, forward EPS, profit margins, ROE, debt/equity, and free cash flow are null/unavailable in the data.
• Analyst consensus and target price are null; no recommendation key provided.
• Alignment: Fundamentals show a large-cap, low-beta, profitable issuer near 52-week highs with a premium trailing P/E of 36.90. This supports the embedded technical strength (price above SMAs) but offers no margin/earnings-trend detail to confirm acceleration.

Current Market Position

Current price per indicators is $678.68 (2026-10-22 close). Recent daily action: 2026-10-21 closed $696.78 on 2.97M volume (high $705.79, low $661.30); 2026-10-22 closed $678.68 on 2.53M volume (high $703.20, low $674.10). From minute bars on 2026-10-21 open $665.00 → intraday high $692.85 early, later hit $701.72 by 09:45; on 2026-10-22 15:55 final bar close $675.81 (low $675.81, volume 198,873). Intraday momentum faded into the close with last 5 minute bars between $675.81 and $678.68.

Technical Analysis

SMA alignment is bullish: SMA 5 ($686.95) > SMA 20 ($672.73) > SMA 50 ($643.66), though price ($678.68) is below SMA 5 and above SMA 20. RSI 58.04 shows moderate bullish momentum without overbought. MACD (12.88) above signal (10.30) with positive histogram (2.58) confirms bullish bias. Bollinger Bands: price inside bands, mid $672.73, upper $701.00, lower $644.47 — no squeeze signal. 30-day range: price is ~76% up the range (($678.68-$605.65)/($705.79-$605.65) = 73.0% by calc; near upper half).

True Sentiment Analysis (Delta 40-60 Options)

Options flow sentiment is Bullish. Call dollar volume $1,873,860 vs put dollar volume $353,870; call pct 84.1%, put pct 15.9%. Contracts: 375 calls / 107 puts. Total directional options analyzed 42 of 2,176 (filter 1.9%). Pure directional conviction is strongly call-weighted, implying expectations of upside continuation into the 2026-11-20 expiration. No divergence vs technicals (both bullish); only mild caution from price closing below SMA 5 on 2026-10-22.

Call Volume: $1,873,860 (84.1%) Put Volume: $353,870 (15.9%) Total: $2,227,730

Key Price Levels (Observational Only)